Live Database

Opportunities
Search

Search the internal Cuberfy opportunities database for grants, startup programs, tenders, cloud credits and funding calls.

Searching the internal opportunities database and preparing the best matching records.
All Tenders Grants Funding Projects
46366 opportunities · Page 1550 of 1855
Save after changing Favorites. Use Share Link when you want the same list on another device.
Your link (Favorites):
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Guselkumab (ausschließlich in der Wirkstärke 100mg), (OBO), ATC L04AC16 für die Zeit 01.12.2024 - 30.11.2026
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 5, 2026
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Flupentixol, ATC N05AF01
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 5, 2026
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Botulinumtoxin Typ A (OBO), ATC M03AX21 für die Zeit 01.12.2024 - 30.11.2026
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 5, 2026
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tobramycin (ausschl. Hartkapseln mit Pulver zur Inhalation), (OBO), ATC J01GB01 f. d. Z. 01.12.24-30.11.26
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 5, 2026
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Elafibranor (OBO), ATC A05AX06 für die Zeit 01.12.2024 - 30.11.2026
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 5, 2026
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Bosutinib, ATC L01EA04
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 5, 2026
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Melatonin, ausgenommen Darreichungsform 2 mg Retardtabletten, ATC N05CH01
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 5, 2026
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Erythropoetin (ausschließlich Epoetin zeta), (OBO), ATC B03XA01 für die Zeit 01.12.2024 - 30.11.2026
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 5, 2026
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Dihydrocodein (OBG), ATC R05DA14 für die Zeit 01.12.2024 - 30.11.2026
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 5, 2026
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Vildagliptin, ATC A10BH02
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 5, 2026
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Clomipramin (OBG), ATC N06AA04 für die Zeit 01.12.2024 - 30.11.2026
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 5, 2026
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Trastuzumab, ATC L01FD01
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 5, 2026
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Cladribin (OBO), ATC L04AA40 für die Zeit 01.12.2024 - 30.11.2026
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 5, 2026
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Chlortalidon, ATC C03BA04
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 5, 2026
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Glatirameracetat (ausschließlich Fertigspritzen), (OBO), ATC L03AX13 für die Zeit 01.12.2024 - 30.11.2026
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 5, 2026
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Rituximab, ATC L01FA01
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 5, 2026
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05
TEN
Germany – Dressings – Abschluss nicht-exklusiver Liefervereinbarungen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-Verfahrens
ted.europa.eu
Buyer: AOK Nordost - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 5, 2026
Buyer: AOK Nordost - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05
TEN
Netherlands – Energy-efficiency consultancy services – Open House Flexscans
ted.europa.eu
Buyer: Gemeente Rotterdam | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-10-05
Tender Procurement Contract Netherlands Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 5, 2026
Buyer: Gemeente Rotterdam | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-10-05
TEN
Netherlands – Energy-efficiency consultancy services – Open House Flexscans
ted.europa.eu
Buyer: Gemeente Rotterdam | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-10-05
Tender Procurement Contract Netherlands Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 5, 2026
Buyer: Gemeente Rotterdam | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-10-05
GRA
DoW, Peer Reviewed Cancer, Impact Award
grants.gov
Summary: The fiscal year 2026 (FY26) Peer Reviewed Cancer Research Program (PRCRP) Impact Award supports mature research that will have a near-term im...
Grant Cash Grant United States Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 5, 2026
Summary: The fiscal year 2026 (FY26) Peer Reviewed Cancer Research Program (PRCRP) Impact Award supports mature research that will have a near-term impact on clinical cancer care in one of the congressionally directed FY26 PRCRP Topic Areas. Applicants must consider how the research project will lead to the advancement of knowledge in cancer research, patient care and/or treatment options in the Military Health System (MHS).Distinctive Features:• Applications must include preliminary data to support feasibility of the study.• Projects must have strong potential to result in a near-term impact in cancer.• The funding mechanism allows clinical trials.• This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. Only the Initiating PI will submit a pre-application, but both PIs will need to submit full applications. The Partnering PI’s application is an abbreviated package specific to their distinct...
GRA
DoW Peer Reviewed Cancer, Clinical Trial Award
grants.gov
Summary: The fiscal year 2026 (FY26) Peer Reviewed Cancer Research Program (PRCRP) Clinical Trial Award (CTA) supports the rapid implementation of cli...
Grant Cash Grant United States Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 5, 2026
Summary: The fiscal year 2026 (FY26) Peer Reviewed Cancer Research Program (PRCRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of cancer within at least one of the FY26 PRCRP Topic Areas. Clinical trials proposed may evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first-in-human, phase 0) that evaluate the effects of interventions or inform the design of more advanced trials to large-scale trials (up to phase III) to determine efficacy in relevant patient populations.Distinctive Features:• Applications to this award mechanism must include a clinical trial.• Projects can range from phase 0 to phase III.• If an Investigational New Drug (IND) application, Investigational Device Exemption (IDE), or equ...
GRA
DoW Peer Reviewed Cancer, Idea Award
grants.gov
Summary: The fiscal year 2026 (FY26) Peer Reviewed Cancer Research Program (PRCRP) Idea Award (IA) supports innovative, untested, high-risk/potentiall...
Grant Cash Grant United States Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 5, 2026
Summary: The fiscal year 2026 (FY26) Peer Reviewed Cancer Research Program (PRCRP) Idea Award (IA) supports innovative, untested, high-risk/potentially high-reward concepts, theories, paradigms, and/or basic cancer research. The advancement of knowledge in cancer research, patient care, and/or treatment options in the Military Health System (MHS) is critical to Service Members, Veterans, other military beneficiaries and the American public.Distinctive Features: The proposed project should demonstrate creative thinking and innovation.• Incremental advances, the next logical step, or switching a model system from one cancer to another cancer are not appropriate for this award.• Inclusion of preliminary data is not required; however, the project must be based on strong scientific rationale.• New for FY26: Early Career Investigator Option: The Early Career Investigator option is designed to support the continued development of promising independent investigators that are early in their fac...
GRA
Youth-Driven Social Media Design: Safe, Inclusive, and Publicly-Owned Social Media
ec.europa.eu
Expected Impact:The developed solutions should demonstrate their potential in concrete terms through the execution of a first roll-out stage during th...
Grant Cash Grant Europe Open
AmountExpected EU contribution: not specified - 1,480,000 EUR
DeadlineOct 6, 2026
Expected Impact:The developed solutions should demonstrate their potential in concrete terms through the execution of a first roll-out stage during the project life-cycle, with a strong uptake strategy guiding their future adoption after the end of the project. The sustainability of the results and their continued benefits to users is a key ambition of this call for proposals.The project is furthermore expected to make a strong impact for the wider ecosystem of European decentralised social media. The insights gained on youth needs and desires on mental-health and inclusivity friendly social media should benefit the wider community of stakeholders in this space, and wherever possible developed technology should contribute to the software stacks of the ActivityPub and ATProtocol communities.Finally, the project should generate insights on the opportunities and challenges for decentralised...
DEV
Rail – studies, works or mixed
ec.europa.eu
Objective:The objective of this call is to develop rail transport infrastructure projects on the TEN-T core[1] network. Scope:Works and / or studies r...
Development Opportunity Cash Grant Europe Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 6, 2026
Objective:The objective of this call is to develop rail transport infrastructure projects on the TEN-T core[1] network. Scope:Works and / or studies related to: Construction/upgrading of cross-border and missing links; Interconnections between rail and other modes of transport, namely inland waterway and maritime transport (including port hinterland connections) and projects aimed at the integration of the high-speed rail and air networks to make the feeder network for long-haul flights more sustainable. Priority will be given to projects fostering the development of high-speed rail in line with the Commission communication on high-speed rail [2].Support will not be given to railway stations, except for railway infrastructure components. If the project includes such components, they shall be presented as a separate work package. Support will not be given to track side ERTMS deployment, e...
DEV
Adaptation of the TEN-T to civilian-defence dual use - studies, works or mixed
ec.europa.eu
Objective:The objective of this call is to develop dual-use transport infrastructure on the TEN-T and the military mobility networks.Scope:In accordan...
Development Opportunity Cash Grant Europe Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 6, 2026
Objective:The objective of this call is to develop dual-use transport infrastructure on the TEN-T and the military mobility networks.Scope:In accordance with Article 9(2), point (c), and Article 12 of the CEF Regulation, support will be provided to dual-use projects, works and/or studies, addressing both civilian and defence needs.As provided in Article 12(1) of the CEF Regulation, dual-use projects must be located on the TEN-T and on the EU military mobility network established by the Council in November 2018, last updated in March 2025 [1]. Priority will be given to projects located on the four EU military mobility priority corridors and projects located in two or more Member States [2].As provided in Article 12(1), point (c) of the CEF Regulation, such projects are to take into account the infrastructure requirements applicable to certain categories of dual-use infrastructure actions,...
📅 Best viewed on desktop - or rotate your phone to landscape mode.
# Opportunity Type Region / Country Amount Deadline Source
38726 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Guselkumab (ausschließlich in der Wirkstärke 100mg), (OBO), ATC L04AC16 für die Zeit 01.12.2024 - 30.11.2026 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 5, 2026 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05

38727 Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Flupentixol, ATC N05AF01 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 5, 2026 Open TED / Tenders Electronic Daily
Source description

Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05

38728 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Botulinumtoxin Typ A (OBO), ATC M03AX21 für die Zeit 01.12.2024 - 30.11.2026 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 5, 2026 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05

38729 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tobramycin (ausschl. Hartkapseln mit Pulver zur Inhalation), (OBO), ATC J01GB01 f. d. Z. 01.12.24-30.11.26 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 5, 2026 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05

38730 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Elafibranor (OBO), ATC A05AX06 für die Zeit 01.12.2024 - 30.11.2026 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 5, 2026 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05

38731 Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Bosutinib, ATC L01EA04 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 5, 2026 Open TED / Tenders Electronic Daily
Source description

Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05

38732 Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Melatonin, ausgenommen Darreichungsform 2 mg Retardtabletten, ATC N05CH01 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 5, 2026 Open TED / Tenders Electronic Daily
Source description

Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05

38733 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Erythropoetin (ausschließlich Epoetin zeta), (OBO), ATC B03XA01 für die Zeit 01.12.2024 - 30.11.2026 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 5, 2026 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05

38734 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Dihydrocodein (OBG), ATC R05DA14 für die Zeit 01.12.2024 - 30.11.2026 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 5, 2026 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05

38735 Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Vildagliptin, ATC A10BH02 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 5, 2026 Open TED / Tenders Electronic Daily
Source description

Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05

38736 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Clomipramin (OBG), ATC N06AA04 für die Zeit 01.12.2024 - 30.11.2026 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 5, 2026 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05

38737 Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Trastuzumab, ATC L01FD01 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 5, 2026 Open TED / Tenders Electronic Daily
Source description

Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05

38738 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Cladribin (OBO), ATC L04AA40 für die Zeit 01.12.2024 - 30.11.2026 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 5, 2026 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05

38739 Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Chlortalidon, ATC C03BA04 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 5, 2026 Open TED / Tenders Electronic Daily
Source description

Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05

38740 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Glatirameracetat (ausschließlich Fertigspritzen), (OBO), ATC L03AX13 für die Zeit 01.12.2024 - 30.11.2026 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 5, 2026 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05

38741 Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Rituximab, ATC L01FA01 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 5, 2026 Open TED / Tenders Electronic Daily
Source description

Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05

38742 Germany – Dressings – Abschluss nicht-exklusiver Liefervereinbarungen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-Verfahrens Buyer: AOK Nordost - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 5, 2026 Open TED / Tenders Electronic Daily
Source description

Buyer: AOK Nordost - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-05

38743 Netherlands – Energy-efficiency consultancy services – Open House Flexscans Buyer: Gemeente Rotterdam | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-10-05 Tender Procurement Contract Netherlands Not provided on the source page. Please check the official source. Open Oct 5, 2026 Open TED / Tenders Electronic Daily
Source description

Buyer: Gemeente Rotterdam | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-10-05

38744 Netherlands – Energy-efficiency consultancy services – Open House Flexscans Buyer: Gemeente Rotterdam | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-10-05 Tender Procurement Contract Netherlands Not provided on the source page. Please check the official source. Open Oct 5, 2026 Open TED / Tenders Electronic Daily
Source description

Buyer: Gemeente Rotterdam | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-10-05

38745 DoW, Peer Reviewed Cancer, Impact Award Summary: The fiscal year 2026 (FY26) Peer Reviewed Cancer Research Program (PRCRP) Impact Award supports mature research that will... Grant Cash Grant United States Not provided on the source page. Please check the official source. Open Oct 5, 2026 Open Grants.gov
Source description

Summary: The fiscal year 2026 (FY26) Peer Reviewed Cancer Research Program (PRCRP) Impact Award supports mature research that will have a near-term impact on clinical cancer care in one of the congressionally directed FY26 PRCRP Topic Areas. Applicants must consider how the research project will lead to the advancement of knowledge in cancer research, patient care and/or treatment options in the Military Health System (MHS).Distinctive Features:• Applications must include preliminary data to support feasibility of the study.• Projects must have strong potential to result in a near-term impact in cancer.• The funding mechanism allows clinical trials.• This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. Only the Initiating PI will submit a pre-application, but both PIs will need to submit full applications. The Partnering PI’s application is an abbreviated package specific to their distinct portion of the research project. Be advised, both applications for a research project may be withdrawn if the initiating or partnering application is rejected or administratively withdrawn.

38746 DoW Peer Reviewed Cancer, Clinical Trial Award Summary: The fiscal year 2026 (FY26) Peer Reviewed Cancer Research Program (PRCRP) Clinical Trial Award (CTA) supports the rapid i... Grant Cash Grant United States Not provided on the source page. Please check the official source. Open Oct 5, 2026 Open Grants.gov
Source description

Summary: The fiscal year 2026 (FY26) Peer Reviewed Cancer Research Program (PRCRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of cancer within at least one of the FY26 PRCRP Topic Areas. Clinical trials proposed may evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first-in-human, phase 0) that evaluate the effects of interventions or inform the design of more advanced trials to large-scale trials (up to phase III) to determine efficacy in relevant patient populations.Distinctive Features:• Applications to this award mechanism must include a clinical trial.• Projects can range from phase 0 to phase III.• If an Investigational New Drug (IND) application, Investigational Device Exemption (IDE), or equivalent, is required, a regulatory application must be submitted to the relevant regulatory agency by the Clinical Trial Award application submission deadline. The regulatory application should be specific to the product and indication to be tested in the proposed clinical trial.• Applications are required to include patient advocates.• Animal studies are NOT allowed under this award mechanism. All preclinical work must be completed prior to the award start date.

38747 DoW Peer Reviewed Cancer, Idea Award Summary: The fiscal year 2026 (FY26) Peer Reviewed Cancer Research Program (PRCRP) Idea Award (IA) supports innovative, untested,... Grant Cash Grant United States Not provided on the source page. Please check the official source. Open Oct 5, 2026 Open Grants.gov
Source description

Summary: The fiscal year 2026 (FY26) Peer Reviewed Cancer Research Program (PRCRP) Idea Award (IA) supports innovative, untested, high-risk/potentially high-reward concepts, theories, paradigms, and/or basic cancer research. The advancement of knowledge in cancer research, patient care, and/or treatment options in the Military Health System (MHS) is critical to Service Members, Veterans, other military beneficiaries and the American public.Distinctive Features: The proposed project should demonstrate creative thinking and innovation.• Incremental advances, the next logical step, or switching a model system from one cancer to another cancer are not appropriate for this award.• Inclusion of preliminary data is not required; however, the project must be based on strong scientific rationale.• New for FY26: Early Career Investigator Option: The Early Career Investigator option is designed to support the continued development of promising independent investigators that are early in their faculty appointments.

38748 Youth-Driven Social Media Design: Safe, Inclusive, and Publicly-Owned Social Media Expected Impact:The developed solutions should demonstrate their potential in concrete terms through the execution of a first roll... Grant Cash Grant Europe Expected EU contribution: not specified - 1,480,000 EUR Open Oct 6, 2026 Open EU Funding & Tenders Portal
Source description

Expected Impact:The developed solutions should demonstrate their potential in concrete terms through the execution of a first roll-out stage during the project life-cycle, with a strong uptake strategy guiding their future adoption after the end of the project. The sustainability of the results and their continued benefits to users is a key ambition of this call for proposals.The project is furthermore expected to make a strong impact for the wider ecosystem of European decentralised social media. The insights gained on youth needs and desires on mental-health and inclusivity friendly social media should benefit the wider community of stakeholders in this space, and wherever possible developed technology should contribute to the software stacks of the ActivityPub and ATProtocol communities.Finally, the project should generate insights on the opportunities and challenges for decentralised...

38749 Rail – studies, works or mixed Objective:The objective of this call is to develop rail transport infrastructure projects on the TEN-T core[1] network. Scope:Work... Development Opportunity Cash Grant Europe Not provided on the source page. Please check the official source. Open Oct 6, 2026 Open EU Funding & Tenders Portal
Source description

Objective:The objective of this call is to develop rail transport infrastructure projects on the TEN-T core[1] network. Scope:Works and / or studies related to: Construction/upgrading of cross-border and missing links; Interconnections between rail and other modes of transport, namely inland waterway and maritime transport (including port hinterland connections) and projects aimed at the integration of the high-speed rail and air networks to make the feeder network for long-haul flights more sustainable. Priority will be given to projects fostering the development of high-speed rail in line with the Commission communication on high-speed rail [2].Support will not be given to railway stations, except for railway infrastructure components. If the project includes such components, they shall be presented as a separate work package. Support will not be given to track side ERTMS deployment, e...

38750 Adaptation of the TEN-T to civilian-defence dual use - studies, works or mixed Objective:The objective of this call is to develop dual-use transport infrastructure on the TEN-T and the military mobility networ... Development Opportunity Cash Grant Europe Not provided on the source page. Please check the official source. Open Oct 6, 2026 Open EU Funding & Tenders Portal
Source description

Objective:The objective of this call is to develop dual-use transport infrastructure on the TEN-T and the military mobility networks.Scope:In accordance with Article 9(2), point (c), and Article 12 of the CEF Regulation, support will be provided to dual-use projects, works and/or studies, addressing both civilian and defence needs.As provided in Article 12(1) of the CEF Regulation, dual-use projects must be located on the TEN-T and on the EU military mobility network established by the Council in November 2018, last updated in March 2025 [1]. Priority will be given to projects located on the four EU military mobility priority corridors and projects located in two or more Member States [2].As provided in Article 12(1), point (c) of the CEF Regulation, such projects are to take into account the infrastructure requirements applicable to certain categories of dual-use infrastructure actions,...